Home>Topics>Companies>Bayer AG

Bayer AG

  1. All
  2. Commentary
  3. Headlines
  1. Sanofi buys two equine health products from Bayer


    Wed, 17 Dec 2014

    PARIS, Dec 17 (Reuters) - Sanofi said on Wednesday that Merial, its animal health unit, had reached an agreement with Bayer HealthCare to buy two Bayer equine health products for an undisclosed amount.

  2. Bayer files for European approval of haemophilia drug


    Thu, 4 Dec 2014

    FRANKFURT, Dec 4 (Reuters) - Drugmaker Bayer AG said on Thursday it had filed for approval of its experimental haemophilia drug Bay 81-8973 in Europe and planned to submit applications in other countries in the coming months.

  3. Bayer to seek approval for new haemophilia drug by year-end


    Tue, 2 Dec 2014

    FRANKFURT, Dec 2 (Reuters) - German drugmaker Bayer AG will file for regulatory approval of its experimental haemophilia drug Bay 81-8973 by the end of the year, it said on Tuesday. (Reporting by Ludwig Burger; Editing by Maria Sheahan)

  4. Bayer explores possible sale of diabetes device unit -Bloomberg


    Mon, 24 Nov 2014

    Nov 24 (Reuters) - Germany-based drugmaker Bayer AG is considering the sale of its diabetes device business, Bloomberg reported, citing sources.

  5. Bayer Posts Strong 3Q Led by Pharmaceuticals ; Break Off of No Moat Material Science Group on Track


    Thu, 30 Oct 2014

    by the drug division, Bayer reported strong third-quarter ..... expect the strong growth in pharmaceuticals sales (up 10% year over ..... growth as well. However, Bayer needs to accelerate its ..... consumer group. We believe Bayer can leverage is global

  6. From Barron’s, August 25, 2014 (Part 1)


    Sat, 23 Aug 2014

    emerging-markets, reduced government budgets and increased R&D costs. For those wanting to buy, Novartis [ NVS ] and Bayer [ BAYN .ge/ BAYRY ] are attractive. Pg M7, Asia: Korean steel Posco [5490.sk/ PKX ] and Chinese car maker BYD [1211

  7. Credit Market Outlook: Tight Spreads Will Keep a Lid on Returns


    Thu, 26 Jun 2014

    order to acquire Cadence Pharmaceuticals . While the deal gives ..... example, we only downgraded Bayer 's BAYRY "> BAYRY issuer ..... will significantly expand Bayer 's already well-positioned ..... material science toward Bayer 's health-care operations

  8. ‘Trying to Recapture the Magic’: The Strategy Behind the Pharma M&A Rush


    Fri, 30 May 2014

    Canada’s Valeant Pharmaceuticals wants to acquire botox ..... May, Germany’s Bayer clinched a $14 ..... billion. In India, Sun Pharmaceuticals in April bought Ranbaxy Laboratories ..... consumer division to Bayer , according to Danzon

  9. Change at the Top for IFF; Shares Still a Little Sweet


    Wed, 28 May 2014

    serve as chairman of the board. Andreas Fibig, a board member since 2011 and president and chairman of Bayer HealthCare Pharmaceuticals , will subsequently assume the reins. We think Fibig’s experience at several global health care firms

  10. Allergan Defends Its Territory Against Increased Competition


    Mon, 14 Oct 2013

    VRX Dysport), we think Merz Pharmaceuticals ' launch of Xeomin in 2013 will ..... RHHBY Lucentis and Regeneron/ Bayer 's REGN/BAYRY Eylea in the ..... Allergan's drugs, such as eye pharmaceuticals and skin ointments, face limited

« Prev12345Next »
Content Partners